Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches

Jia Huang, Song Zhai, Fangfan Ye, Song Wang, Manfei Zeng, George Way, Vipul Madahar, Tengfei Zhu, Liping Qiu, Zehui Xu, Manhua Ye, Lei Liu, Xinping Cui, Jiayu Liao
doi: https://doi.org/10.1101/2020.07.29.20164699
Jia Huang
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Song Zhai
2Department of Statistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fangfan Ye
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Song Wang
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manfei Zeng
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Way
3Department of Bioengineering, University of California at Riverside, 900 University Avenue Riverside, CA 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vipul Madahar
3Department of Bioengineering, University of California at Riverside, 900 University Avenue Riverside, CA 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tengfei Zhu
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liping Qiu
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zehui Xu
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manhua Ye
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Liu
1National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, 29 Bulan Road, Longgang District, Shenzhen, China, 518112
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jiayu.liao@ucr.edu xinping.cui@ucr.edu liul2019@mail.sustech.edu.cn
Xinping Cui
2Department of Statistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jiayu.liao@ucr.edu xinping.cui@ucr.edu liul2019@mail.sustech.edu.cn
Jiayu Liao
3Department of Bioengineering, University of California at Riverside, 900 University Avenue Riverside, CA 92521
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jiayu.liao@ucr.edu xinping.cui@ucr.edu liul2019@mail.sustech.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Various medical treatments for COVID-19 are attempted. After patients are discharged, SARS-CoV-2 recurring cases are reported and the recurrence could profoundly impact patient healthcare and social economics. To date, no data on the effects of medical treatments on recurrence has been published. We analyzed the treatment data of combinations of ten different drugs for the recurring cases in a single medical center, Shenzhen, China. A total of 417 patients were considered and 414 of them were included in this study (3 deaths) with mild-to-critical COVID-19. Patients were treated by 10 different drug combinations and followed up for recurrence for 28 days quarantine after being discharged from the medical center between February and May, 2020. We applied the Synthetic Minority Oversampling Technique (SMOTE) to overcome the rare recurring events in certain age groups and performed Virtual Twins (VT) analysis facilitated by random forest regression for medical treatment-recurrence classification. Among those drug combinations, Methylprednisolone/Interferon/Lopinavir/Ritonavir/Arbidol led to the lowest recurring rate (0.133) as compared to the average recurring rate (0.203). For the younger group (age 20-27) or the older group (age 60-70), the optimal drug combinations are different, but the above combination is still the second best. For obese patients, the combination of Ribavirin/Interferon/Lopinavir/Ritonavir/Arbidol led to the lowest recurring rate for age group of 20-50, whereas the combination of Interferon/Lopinavir/Ritonavir/Arbidol led to lowest recurring rate for age group of 50-70. The insights into combinatorial therapy we provided here shed lights on the use of a combination of (biological and chemical) anti-virus therapy and/or anti-cytokine storm as a potentially effective therapeutic treatment for COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

University of California, Riverside. Grant Number: AES‐CE RSAP A01869 for Cui; UCR Academic Award to Jiayu Liao; and National Natural Science Foundation of China (No. 81501651 to Jia Huang

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the treatment plans were approved by the IRB committee of The Second Affiliated Hospital of Southern University of Science and Technology.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data are available upon request, except patient identity information.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
Jia Huang, Song Zhai, Fangfan Ye, Song Wang, Manfei Zeng, George Way, Vipul Madahar, Tengfei Zhu, Liping Qiu, Zehui Xu, Manhua Ye, Lei Liu, Xinping Cui, Jiayu Liao
medRxiv 2020.07.29.20164699; doi: https://doi.org/10.1101/2020.07.29.20164699
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
Jia Huang, Song Zhai, Fangfan Ye, Song Wang, Manfei Zeng, George Way, Vipul Madahar, Tengfei Zhu, Liping Qiu, Zehui Xu, Manhua Ye, Lei Liu, Xinping Cui, Jiayu Liao
medRxiv 2020.07.29.20164699; doi: https://doi.org/10.1101/2020.07.29.20164699

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1437)
  • Dentistry and Oral Medicine (221)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (590)
  • Epidemiology (10339)
  • Forensic Medicine (6)
  • Gastroenterology (534)
  • Genetic and Genomic Medicine (2658)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1746)
  • Health Policy (791)
  • Health Systems and Quality Improvement (683)
  • Hematology (270)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12123)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2486)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (498)
  • Occupational and Environmental Health (569)
  • Oncology (1338)
  • Ophthalmology (404)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (787)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2424)
  • Public and Global Health (5035)
  • Radiology and Imaging (903)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (258)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)